Lentine Krista L, Rocca-Rey Lisa A, Bacchi Giuliana, Wasi Nadia, Schmitz Leslie, Salvalaggio Paolo R, Abbott Kevin C, Schnitzler Mark A, Neri Luca, Brennan Daniel C
Center for Outcomes Research, Saint Louis University School of Medicine, St Louis, MO 63104, USA.
Transplantation. 2008 Jul 27;86(2):303-12. doi: 10.1097/TP.0b013e31817ef0f9.
The cardiac implications of obesity in kidney transplant recipients are not well-described.
We examined associations of body mass index (BMI) at transplant with posttransplant cardiac risk among 1102 renal allograft recipients at a single center in 1991 to 2004. Cumulative posttransplant incidences of congestive heart failure (CHF), atrial fibrillation (AF), myocardial infarction, and a composite of these cardiac diagnoses were estimated by the Kaplan-Meier method. Bivariate (hazards ratio) and covariate (adjusted hazards ratio) relationships of BMI increments with cardiac risk were modeled by Cox's regression. We also systematically reviewed the literature on BMI and cardiac events after transplant.
In the local data, 5-year cumulative incidence of any cardiac diagnosis rose from 8.67% to 29.35% across the lowest to highest BMI quartiles (P=0.02), driven primarily by increases in CHF and AF. In contrast, the rate of myocardial infarction did not differ by BMI quartile (P=0.56). Each 5 U BMI increase predicted 25% higher risk of the cardiac composite (hazards ratio 1.25, 95% CI 1.07-1.47, P=0.005), a relationship that persisted with significance after covariate adjustment (adjusted hazards ratio 1.19, 95% CI 1.00-1.43, P=0.049). BMI independently predicted cardiac risk in subcohorts with pretransplant heart disease and with nondiabetic renal failure. Data from 26 original articles support BMI as a risk factor for posttransplant CHF and AF, whereas findings for coronary/ischemic outcomes are inconsistent and predominantly negative.
High BMI at transplant predicts increased cardiac risk, especially of CHF and AF. Further research should examine whether obesity treatment modifies cardiac risk after kidney transplantation.
肥胖对肾移植受者心脏方面的影响尚未得到充分描述。
我们在1991年至2004年期间对单中心的1102例肾移植受者进行了研究,探讨移植时体重指数(BMI)与移植后心脏风险之间的关联。采用Kaplan-Meier方法估计充血性心力衰竭(CHF)、心房颤动(AF)、心肌梗死以及这些心脏诊断综合结果的移植后累积发病率。通过Cox回归对BMI增量与心脏风险的双变量(风险比)和协变量(调整后风险比)关系进行建模。我们还系统回顾了关于BMI与移植后心脏事件的文献。
在本地数据中,从BMI最低四分位数到最高四分位数,任何心脏诊断的5年累积发病率从8.67%升至29.35%(P = 0.02),主要由CHF和AF的增加所致。相比之下,心肌梗死发生率在各BMI四分位数之间无差异(P = 0.56)。BMI每增加5个单位,预测心脏综合事件风险升高25%(风险比1.25,95%可信区间1.07 - 1.47,P = 0.005),在协变量调整后该关系仍具有显著性(调整后风险比1.19,95%可信区间1.00 - 1.43,P = 0.049)。BMI在移植前有心脏病和非糖尿病性肾衰竭的亚组中独立预测心脏风险。来自26篇原始文章的数据支持BMI作为移植后CHF和AF的危险因素,而关于冠状动脉/缺血性结局的研究结果不一致且大多为阴性。
移植时高BMI预示心脏风险增加,尤其是CHF和AF。进一步研究应探讨肥胖治疗是否能改变肾移植后的心脏风险。